Dapagliflozin and cardiovascular outcomes in type 2 diabetes

New England Journal of Medicine

Volumn 380, Issue 4, 2019, Pages 347-357

  Wiviott, S D ^a   Raz, I ^a   Bonaca, M P ^a   Mosenzon, O ^a   Kato, E T ^a   Cahn, A ^a   Silverman, M G ^a   Zelniker, T A ^a   Kuder, J F ^a   Murphy, S A ^a   Bhatt, D L ^a   Leiter, L A ^a   McGuire, D K ^a   Wilding, J P H ^a   Ruff, C T ^a   Nilsson, G I ^a   Fredriksson, M ^a   Johansson, P A ^a   Langkilde, A M ^a   Sabatine, M S ^a   Bansilal, S ^b   Furtado, R ^b   Fish, M P ^b   Gabovitch, D ^b   Jevne, A ^b   Ahern, S ^b   Im, K ^b   Goodrich, E L ^b   Lowe, C ^b   Fisher, N ^b   Gannon, J ^b   Trindade, S ^b   Towarowski, A ^b   Fox, Y ^b   Johnsson, E ^b   Ranft, S ^b   Faber, B ^b   Wallander, M ^b   Weiss, A ^b   Buskila, A ^b   Abola, M T B ^b   Ardissino, D ^b   Averkov, O ^b   Aylward, P ^b   Bode, C ^b   Bonnici, F ^b   Bonora, E ^b   Budaj, A J ^b   Cernea, S ^b   Chiang, C E ^b   Cooper, M ^b   Dalby, A ^b   Deerochanawong, C ^b   Dellborg, M ^b   Diaz, R ^b   Dimulescu, D ^b   Eliaschewitz, F G ^b   Goudev, A R ^b   Hadjadj, S ^b   Herrera, M ^b   Huo, Y ^b   Jermendy, G ^b   Ji, L ^b   Kadowaki, T ^b   Kiss, R ^b   Kooy, A ^b   Kumar, K M P ^b   Lewis, B ^b   Litwak, L ^b   Lopez Sendon, J ^b   Ma, R ^b   Merlini, P A ^b   Nauck, M A ^b   Nguyen, T K ^b   Nicolau, J C ^b   Ostgren, C J ^b   Ophuis, T O ^b   Padilla, F ^b   Pais, P ^b   Park, K S ^b   Parkhomenko, A ^b   Ray, K ^b   Rosenstock, J ^b   Ruda, M ^b   Satman, I ^b   Shestakova, M ^b   Smahelova, A ^b   Spinar, J ^b   Strojek, K ^b   Sy, R ^b   Tankova, T ^b   Theroux, P ^b   Tkac I ^b   Van Gaal, L ^b   Wainstein, J ^b   Harrington, R A ^b   Droller, M J ^b   Lee, K L ^b   Nesto, R W ^b   Tuomilehto, J ^b   Hedlin, H ^b   Desai, M ^b   Sayfer, I ^b   Alexanian, S ^b   Awtry, E ^b   Bentley Lewis, R ^b   Berger, C J ^b   Croce, K ^b   Desai, A ^b   Garg, R K ^b   Gelfand, E ^b   Gignac, G ^b   Goessling, W ^b   Ho, C ^b   Hochberg, E ^b   Lane, A ^b   Larrey, D ^b   Leeman, D E ^b   Lewis, J ^b   Link, M S ^b   McDonnell, M E ^b   Norden, A D ^b   Pande, A ^b   Rosenberg, C ^b   Rost, N ^b   Ruberg, F ^b   Schiff, E ^b   Silverman, S ^b   Singhal, A ^b   Wagner, A ^b   Wolpin, B ^b   Aizenberg, D ^b   Fernandez M ^b   Sala, J ^b   Maffei, L ^b   Luquez, C ^b   Waitman, J ^b   Rista, L ^b   Nardone, L ^b   Sposetti, G ^b   Cantero, M ^b   Alvarisqueta, A ^b   Montana O ^b   Cuadrado, J ^b   Cartasegna, L ^b   Baccaro, C ^b   Chertkoff, A ^b   Sanabria, H ^b   Vainstein, N ^b   Amerena, J ^b   Arya, K ^b   d'Emden, M ^b   Proietto, J ^b   Moses, R ^b   Colquhoun, D ^b   Stranks, S ^b   Lehman, R ^b   Hamilton, A ^b   Whelan, A ^b   Simpson, R ^b   Purnell, P ^b   Abhayaratna, W ^b   Hammett, C ^b   McKeirnan, M ^b   Sullivan, D ^b   Bach, L ^b   Hughes, K ^b   Mathieu, C ^b   Vercammen, C ^b   Scheen, A ^b   Duyck, F ^b   Cools, F ^b   De Wolf, L ^b   Verhaegen, A ^b   Nobels, F ^b   Missault, L ^b   Crenier, L ^b   Thoeng, J ^b   Wollaert, B ^b   Vandenbroucke, M ^b   Eliaschewitz, F ^b   Borges, J L C ^b   Turatti, L ^b   Lima, F G ^b   dos Santos, F ^b   Kerr Saraiva, J ^b   Pereira, M ^b   Pereira, A ^b   Precoma, D B ^b   Filho, G F V ^b   Reis, G ^b   Maia, L N ^b   Bacheva, T ^b   Temelkova Kurktschiev, T ^b   Maneva, S ^b   Stoyanovska, B ^b   Boshnyashka, R ^b   Stoykova, Y ^b   Georgiev, D ^b   Tagarev, Z ^b   Dimitrova, E ^b   Vitkina, M ^b   Yordanova, L ^b   Temelkova, M ^b   Vasileva, S ^b   Kuneva, T ^b   Zyumbyuleva, M ^b   Daskalova, I ^b   Genadieva, V ^b   Boyanov, L ^b   Farah, G ^b   Lazarova, G ^b   Georgieva, M ^b   Krasteva, S ^b   Slavcheva, A ^b   Yabroudi, N ^b   Veleva, N ^b   Zlateva, A ^b   Damyanova, V ^b   Elenkova, A ^b   Kotselova, T ^b   Genov, K ^b   Lyubenova, L ^b   Temelkova, N ^b   Harizanova, B ^b   Zaharieva, S ^b   Bajaj, H ^b   Goldenberg, R ^b   Aronson, R ^b   Twum Barima, D ^b   Dumas, R ^b   Kouz, S ^b   Kaiser, S M ^b   Ajala, B ^b   Cha, J ^b   Teitelbaum, I ^b   Chouinard, G ^b   Woo, V ^b   Dan Dattani, I ^b   Mazza, G ^b   Gaudet, D ^b   Poirier, P ^b   Conway, J ^b   Dion, D ^b   McKeough, M ^b   Manyari, D ^b   Harris, S ^b   St Pierre, B ^b   Yale, J F ^b   Landry, D ^b   Gupta, M ^b   Hramiak, I ^b   Lau, D ^b   DeGrace, M ^b   Gallo, R ^b   Montigny, M ^b   Dzongowski, P ^b   Liutkus, J ^b   Frechette, A ^b   Gosselin, G ^b   Sabbah, E ^b   Langlois, M F ^b   Rabasa Lhoret, R ^b   Bedard, J ^b   Hart, R ^b   Dowell, A ^b   Pandey, A ^b   O'Keefe, D ^b   Hill, L ^b   Weisnagel, S J ^b   Muirhead, N ^b   Zimmermann, R ^b   Galiwango, P ^b   Tobe, S ^b   Priestman, B ^b   Zinman, B ^b   Ma, J ^b   Zhao, X ^b   Wang, C ^b   Zhang, A ^b   Dong, Y ^b   Dong, X ^b   Luo, M ^b   Guo, J ^b   Zheng, Z ^b   Li, Y ^b   Liang, Y ^b   Peng, D ^b   Spinar J ^b   Maderic D ^b   Smahelova A ^b   Spinarova L ^b   Raclavska L ^b   Ludka, O ^b   Rihacek I ^b   Karasova J ^b   Pelikanova M ^b   Vlasakova H ^b   Urbancova K ^b   Zamrazil, V ^b   Hradec, J ^b   Vlasicova H ^b   Racicka E ^b   Okenka L ^b   Naplava R ^b   Skopecek J ^b   Palova S ^b   Krystl, T ^b   Pistek Z ^b   Oznerova M ^b   Andresova A ^b   Sarbochova R ^b   Taborska P ^b   Petrova I ^b   Stanek L ^b   Reichert, P ^b   Lorenc, Z ^b   Szabo M ^b   Petit, C ^b   Krempf, M ^b   Boye, A ^b   Dubois, S ^b   Clavel, S ^b   Gourdy, P ^b   Elbaz, M ^b   Jazayeri, S ^b   Gouet, D ^b   Verges, B ^b   Couffinhal, T ^b   Sendeski, M ^b   Klausmann, G ^b   Appel, K ^b   Pein, M ^b   Thieme, R ^b   Schumm Draeger, P ^b   Jacob, S ^b   Toursarkissian, N ^b   Kleinecke Pohl, U ^b   Tschope D ^b   Ott, P ^b   Haak, T ^b   Nauck, M ^b   Derwahl, K ^b   Bugger, H ^b   Hui, G ^b   Tsang, C ^b   Zilahi, Z ^b   Puski L ^b   Vangel, S ^b   Fulop T ^b   Pall K ^b   Hidvegi T ^b   Revesz K ^b   Koranyi L ^b   Kajetan M ^b   Kerenyi Z ^b   Penzes J ^b   Herczeg, B ^b   Laszloczky A ^b   Turi, T ^b   Rapi, J ^b   Pentek Z ^b   Gaal Z ^b   Winkler, G ^b   Percs, E ^b   Czigany A ^b   Harcsa, E ^b   Gurzo M ^b   Tassaly, J ^b   Horthy, R ^b   Petro G ^b   Farago K ^b   Muller G ^b   Varju, I ^b   Kirschner, R ^b   Kiss, I ^b   Bakai, J ^b   Kancz, S ^b   Marton, Z ^b   Kodur, R ^b   Yajnik, C ^b   Thomas, N ^b   Ayyar, V ^b   Iyengar, P ^b   Bashkin, A ^b   Daoud, D ^b   Itzhak, B ^b   Katz, A ^b   Tsur, A ^b   Nikolsky, E ^b   Atar, S ^b   Grossman, A ^b   Klainman, E ^b   Tsalihin, D ^b   Shotan, A ^b   Turgeman, Y ^b   Ferrario, M ^b   Merlini, P ^b   Piatti, P ^b   Zenari, L ^b   Trevisan, R ^b   Bosco, B ^b   Di Lorenzo, L ^b   Mannucci, E ^b   Avogaro, A ^b   Reimers, B ^b   Trimarco, B ^b   Silvestri, O ^b   Salvioni, A ^b   Nakagawa, H ^b   Sueyoshi, A ^b   Fukuda, K ^b   Yasumoto, H ^b   Matsubayashi, S ^b   Kawajiri, K ^b   Togashi, Y ^b   Senokuchi, T ^b   Ohta, Y ^b   Yamauchi, T ^b   Node, K ^b   Alcocer Gamba, M ^b   Herrera Marmolejo, M ^b   De los Rios Ibarra, M ^b   Gonzalez Galvez G ^b   Garcia Cantu E ^b   Leguizamo Dimas A ^b   Luna Ceballos, R ^b   Medina Pech, C ^b   Stobschinski de Alba, C ^b   Gonzalez Gonzalez J ^b   Padilla Padilla, F ^b   Fanghanel Salmon G ^b   Robles Torres, F ^b   Lopez Rosas E ^b   Pelayo Orozco, E ^b   Banda Elizondo, R ^b   Escalona Caamano A ^b   Frenk Baron, P ^b   Aguilar Salinas, C ^b   Mustieles Rocha, C ^b   Vidrio Velazquez M ^b   Rodriguez Briones I ^b   Saldate Alonso, M ^b   Velasco Sanchez R ^b   Groenemeijer, B ^b   Ronner, E ^b   Kuijper, A ^b   Strikwerda, S ^b   Van Kempen, W ^b   Gijsbers, S ^b   Oude Ophuis, A ^b   Swart, H ^b   Hoogenberg, K ^b   Hovens, M ^b   van Hessen, M ^b   Westerink, J ^b   Kragten, J ^b   Nierop, P ^b   Bax, W ^b   Hartong, S ^b   Nieuwdorp, M ^b   Gonkel, F ^b   Al Windy, N ^b   Troquay, R ^b   Schaafsma, H ^b   Lieverse, A ^b   Knufman, N ^b   Tirador, L ^b   Guenon, M ^b   Ferrolino, A ^b   Atilano, A ^b   Aportadera, M ^b   Que, M ^b   Denopol, M ^b   Tolentino, M ^b   Jimeno, C ^b   Wee, J ^b   Mirasol, R ^b   Panelo, A ^b   Roxas, D ^b   Abola, M ^b   Palmes, P ^b   Silva, A ^b   Salvador, D ^b   Rosita, R ^b   Maravilla, L ^b   Rogelio, G ^b   Pacheco, E ^b   Tin Hay, L ^b   Prado, J ^b   Krzyzagorska E ^b   Witek, R ^b   Miklaszewicz B ^b   Sudnik, W ^b   Pomiecko W ^b   Bochenek, A ^b   Fares, I ^b   Wujkowski, M ^b   Korol, M ^b   Powierza S ^b   Goch, A ^b   Miekus P ^b   Siegel, A ^b   Skierkowska, J ^b   Romanczuk P ^b   Cygler, J ^b   Landa K ^b   Szyprowska, E ^b   Stachlewski, P ^b   Czerski, T ^b   Pawlowicz L ^b   Sowinski D ^b   Romanowski, L ^b   Rudzki, H ^b   Skorski M ^b   Jasiel Wojculewicz, H ^b   Stasiewski, A ^b   Kania, G ^b   Mirek Bryniarska, E ^b   Wojnowski, L ^b   Korzeniak, R ^b   Oh, T ^b   Park, K ^b   Lee, M ^b   Lee, K ^b   Jang, H ^b   Kim, S ^b   Ku, B ^b   Cha, B ^b   Son, H ^b   Lee, I ^b   Park, J ^b   Yu, S ^b   Shon, H ^b   Rhee, E ^b   Cho, J ^b   Park, T ^b   Nam, J ^b   Pintilei, E ^b   Popescu, A ^b   Nafornita, V ^b   Gutu, O ^b   Dumitrescu, A ^b   Bala, C ^b   Caceaune, E ^b   Mindrescu, N ^b   Morosanu, M ^b   Bradescu, O ^b   Munteanu, M ^b   Voitec, M ^b   Vlaiculescu, M ^b   Hancu, N ^b   Diaconu Sotropa, M ^b   Lupu, S ^b   Mateescu, A ^b   Carlan, L ^b   Marton, R ^b   Lupusoru, D ^b   Mot, A ^b   Coman, A ^b   Zaharie, D ^b   Rebrov, A ^b   Shutemova, E ^b   Bolieva, L ^b   Khalimov, Y ^b   Statsenko, M ^b   Galyavich, A ^b   Koziolova, N ^b   Shapovalova, Y ^b   Pavlysh, E ^b   Strongin, L ^b   Vertkin, A ^b   Vishneva, E ^b   Pavlova, M ^b   Khasanov, N ^b   Antsiferov, M ^b   Gavrisheva, I ^b   Sokolova, N ^b   Vorobyev, S ^b   Morugova, T ^b   Sinitsina, I ^b   Ezhov, A ^b   Kobalava, Z ^b   Belenkiy, D ^b   Supryadkina, T ^b   Kazakov, Y ^b   Oschepkova, E ^b   Dreval, A ^b   Novikova, T ^b   Vishnevsky, A ^b   Chizhov, D ^b   Akatova, E ^b   Vorokhobina, N ^b   Ivanov, I ^b   Dudinskaya, E ^b   Konstantinov, V ^b   Kanderkova D ^b   Pavlik L ^b   Raslova K ^b   Paulovic V ^b   Babikova J ^b   Belesova K ^b   Merciakova M ^b   Truban, J ^b   Vargova A ^b   Fabryova L ^b   Slovenska M ^b   Plasil R ^b   Tomasova L ^b   Kollarova D ^b   Spodniakova D ^b   Kosikova M ^b   Dzuponova J ^b   Kurcova I ^b   Skripova, D ^b   Gabrisova A ^b   Kalinova S ^b   Ranjith, N ^b   Burgess, L ^b   Mitha, I ^b   Conradie, M ^b   Distiller, L ^b   Pillai, P ^b   Pillay, S ^b   Horak, A ^b   Nethononda, R ^b   van den Berg, E ^b   Nortje, H ^b   Bayat, J ^b   Corbett, C ^b   Abelson, M ^b   van Zyl, L ^b   Pillay, T ^b   Wing, J ^b   Kapp, C ^b   Hidalgo Urbano, R ^b   Gonzalez Juanatey, J ^b   Blanco Coronado, J ^b   Bruguera Cortada, J ^b   Ferreiro Gutierrez, J ^b   Quesada Simon, M ^b   Castro, A ^b   Delgado Alvarez E ^b   Freixa, R ^b   Boada, A ^b   Larnefeldt, H ^b   Mooe, T ^b   Koskinen, P ^b   Lagerback P ^b   Linderfalk, C ^b   Liu, B ^b   Berndtsson Blom, K ^b   Tengmark, B ^b   Lindholm, C ^b   Ostgren C ^b   Oweling, M ^b   Albertsson, P ^b   Alvarsson, M ^b   Fant, S ^b   Berglund, O ^b   Hsia, C ^b   Chiang, C ^b   Fang, C ^b   Ueng, K ^b   Wang, K ^b   Lai, W ^b   Mamanasiri, S ^b   Wongvipaporn, C ^b   Kuanprasert, S ^b   Thongsri, T ^b   Srimahachota, S ^b   Boonyavarakul, A ^b   Suwanwalaikorn, S ^b   Tantiwong, P ^b   Sritara, P ^b   Sriwijitkamol, A ^b   Sanguanwong, S ^b   Chotinaiwattarakul, C ^b   Piyayotai, D ^b   Balci, M ^b   Orbay, E ^b   Saygili, F ^b   Oguz, A ^b   Altuntas, Y ^b   Comlekci, A ^b   Karpenko, O ^b   Tkach, S ^b   Vlasenko, M ^b   Fushtey, I ^b   Pertseva, T ^b   Reshotko, D ^b   Mostovoy, Y ^b   Vizir, V ^b   Kraiz, I ^b   Amosova, K ^b   Batushkin, V ^b   Tseluyko, V ^b   Koval, O ^b   Strang, C ^b   Bodalia, B ^b   Pieters, R ^b   Turner, W ^b   Asamoah Owusu, N ^b   White, C ^b   Calvert, J ^b   McNally, D ^b   Jones, N ^b   McKaig, G ^b   Thompson, J ^b   Mohr, S ^b   Simpson, H ^b   Conn, P ^b   McCoye, A ^b   Rivero, O ^b   Yazdani, S ^b   Ince, C ^b   Zeitlin, J ^b   Wharton, T ^b   Platt, G ^b   Anderson, R J ^b   Angueira Serrano, E ^b   Lillestol, M ^b   Hanlon, B ^b   Soufer, J ^b   Garcia, B ^b   Iteld, B ^b   Venugopal, C ^b   Ahmed, A ^b   Duardo Guerra, Y ^b   Jetty, P ^b   Miranda, A ^b   Wahlen, J ^b   Lederman, S ^b   Cohen, K ^b   Lake, L ^b   French, W J ^b   Tahirkheli, N ^b   Baker, S ^b   Stoltz, R ^b   Wilson, J ^b   Nadar, V ^b   Brown, J ^b   Larrain, G ^b   Wiseman, A ^b   Ruoff, G ^b   Williams, M ^b   Tan, A ^b   Hartman, I ^b   Singh, N ^b   Graf, R ^b   Wakefield, P ^b   McNeill, R ^b   Byars, W ^b   Reyes Almodovar, R ^b   Jones, S ^b   Kantaros, L ^b   Hegedosh, N ^b   Graves, M ^b   Bernstein, M ^b   Falkowski, S ^b   Bialow, M ^b   Paraschos, A ^b   Dagher, G ^b   Arif, A ^b   Condit, J ^b   Chaykin, L ^b   Grunstra, B ^b   Earl, J ^b   Unks, D ^b   Srivastava, S ^b   Benson, M ^b   Huffman, C ^b   Miller, G ^b   Willis, J ^b   Bender, K ^b   Martin, E ^b   Blackmore, R ^b   Rohr, K ^b   Chilka, S ^b   Gadowski, G ^b   Fitz Patrick, D ^b   Benjamin, S ^b   Morin, D ^b   Zias Dilena, A ^b   Acosta, R ^b   Claassen, D ^b   Miranda, F ^b   Raad, G ^b   Inzerello, A ^b   Porter, J ^b   Bhattacharya, A ^b   Gutmann, J ^b   Korpas, D ^b   Syed, M ^b   Zieve, F ^b   Raisinghani, A ^b   Alam, S ^b   Bartkowiak, A ^b   Boccalandro, F ^b   Talano, J ^b   Mercado, A ^b   Krichmar, P ^b   Oldfield, C ^b   Adams, K ^b   Gorman, T ^b   Lewis, D ^b   Shah, R ^b   Shockey, G ^b   Lefebvre, G ^b   Andrawis, N ^b   Tami, L ^b   Bittar, N ^b   Khan, M S ^b   Rink, L ^b   Hendrix, E ^b   Wood, J ^b   Robinson, J ^b   Pavon, H ^b   Irfan, M ^b   Gonzalez, E ^b   Singal, R ^b   Shore, K ^b   Saba, F ^b   Bianco, J ^b   Erickson, B ^b   Gorson, D ^b   Puri, S ^b   Arauz Pacheco, C ^b   Forman, S ^b   Akyea Djamson, A ^b   Lieber, I ^b   Barker, B ^b   Desai, P ^b   Sotolongo, C ^b   Steinhoff, J ^b   Hill, R ^b   Radin, M ^b   Patel, R ^b   Lieberman, S ^b   Wenocur, H ^b   Dagogo Jack, S ^b   Lupovitch, S ^b   Ison, R ^b   Bacharach, J M ^b   Diogo, J ^b   Mazzella, M ^b   Greenwald, J ^b   Quadrel, M ^b   Mayer, N ^b   Datu, J ^b   McCartney, M ^b   Bruce, T ^b   Singal, D ^b   Turner, J ^b   Videau, B ^b   Fritz, R ^b   Fox, D ^b   Calatayud, G ^b   Sheldon, W ^b   Kereiakes, D ^b   Thomas, J ^b   Salacata, A ^b   McCullum, K ^b   Harris, B ^b   de Souza, J ^b   Rahman, A ^b   Blumenthal, S ^b   Narayan, P ^b   Bloch, M ^b   Augenbraun, C ^b   Bernstein, R ^b   Perlman, R ^b   Berman, J ^b   LaBryer, L ^b   Wynne, A ^b   Fish, J ^b   Zarich, S ^b   Gabra, N ^b   Popeil, L ^b   Hermany, P ^b   Barreto, A ^b   Pomposini, D ^b   Gonzalez Campoy, J M ^b   Langer, M ^b   Bayron, C ^b   Suneja, R ^b   Kamlet, J ^b   Wheeler, K ^b   Hurley, S ^b   Sharma, S ^b   Wefald, F ^b   Hershon, K ^b   O'Connor, T ^b   Pueblitz, G ^b   Laguerre, J ^b   Amin, M ^b   Alfonso, T ^b   Jaffrani, N ^b   Isserman, S ^b   Portnay, E ^b   Vlastaris, A ^b   Dy, J ^b   Hagan, M ^b   Noveck, H ^b   Kraft, P ^b   Andersen, J ^b   Foley, B ^b   Carr, K ^b   Gelormini, J ^b   Williams, T ^b   Landau, C ^b   Richwine, R ^b   Thakkar, M ^b   Karim, A ^b   Madhun, Z ^b   Francyk, D ^b   Lamantia, J ^b   Baker, B ^b   Zhang, W ^b   Lev, V ^b   Hasan, M ^b   Captain, A ^b   Herzog, W ^b   Friedman, K ^b   Lawson, W ^b   Desai, V ^b   Ow, C ^b   Simons, R ^b   Mandviwala, M ^b   Le, T ^b   Hack, T ^b   Zebrack, J ^b   Henderson, D ^b   DeJulia, J ^b   Mehta, R ^b   Reza, S ^b   Poonawala, R ^b   Awad, A ^b   Velasquez, M ^b   Mohiuddin, S ^b   Salazar Sharma, M ^b   Myrick, G ^b   Gottlieb, D ^b   Ovalle, F ^b   Alfieri, A ^b   Ahmed, S ^b   Bohula, E ^b   Donahoe, S M ^b   Longshaw, K ^b   Eshaghian, S ^b   Lash, J ^b   Goldberg, R K ^b   Fox, B ^b   Mostel, E ^b   Dobies, D ^b   Ward, H ^b   Burbano, J ^b   Puleo, P ^b   Lenhard, M J ^b   Korn, D ^b   Thadani, U ^b   Bradley, A ^b   Kmetzo, J ^b   Heasley, E ^b   Raikhel, M ^b   Mahr, N ^b   Bittar, G ^b   Fuentes, F ^b   Raghu, P ^b   Diep, T T B ^b   Tran, Q K ^b   Tran, N ^b   Nguyen, D ^b   Nguyen V ^b   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DAPAGLIFLOZIN; PLACEBO; 2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; BENZHYDRYL DERIVATIVE; GLUCOSIDE;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; ALL CAUSE MORTALITY; ARTICLE; BLADDER CANCER; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR SYMPTOM; CLINICAL OUTCOME; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC KETOACIDOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENITAL TRACT INFECTION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; AGED; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPLICATION; MORTALITY; STATISTICS AND NUMERICAL DATA;

AGED; BENZHYDRYL COMPOUNDS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSIDES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS;

EID: 85060042753     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1812389     Document Type: Article

References (35)

1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 2011; 123(4): e18-e209.
3. Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765-75.
4. Ahmad FS, Ning H, Rich JD, Yancy CW, Lloyd-Jones DM, Wilkins JT. Hypertension, obesity, diabetes, and heart failure-free survival: The Cardiovascular Disease Lifetime Risk Pooling Project. JACC Heart Fail 2016; 4: 911-9.
5. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999; 341: 1127-33.
6. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. Circulation 2017; 136(6): e137-e161
7. American Diabetes Association. 9. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care 2018; 41: Suppl 1: S86-S104.
8. American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018. Diabetes Care 2018; 41: Suppl 1: S73-S85.
9. Guidance for industry: diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Washington, DC: Department of Health and Human Services, December 2008 (http://www .fda .gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/ucm071627 .pdf).
10. Han S, Hagan DL, Taylor JR, et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes 2008; 57: 1723-9.
11. Komoroski B, Vachharajani N, Feng Y, Li L, Kornhauser D, Pfister M. Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus. Clin Pharmacol Ther 2009; 85: 513-9.
12. Plosker GL. Dapagliflozin: A review of its use in patients with type 2 diabetes. Drugs 2014; 74: 2191-209.
13. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015; 373: 2117-28.
14. Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 2017; 377: 644-57.
15. Mahaffey KW, Neal B, Perkovic V, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin Cardiovascular Assessment Study). Circulation 2018; 137: 323-34.
16. Perkovic V, de Zeeuw D, Mahaffey KW, et al. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS program randomised clinical trials. Lancet Diabetes Endocrinol 2018; 6: 691-704.
17. Cherney DZI, Zinman B, Inzucchi SE, et al. Effects of empagliflozin on the urinary albumin-To-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: An exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2017; 5: 610-21.
18. Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 2016; 375: 323-34.
19. Wiviott SD, Raz I, Bonaca MP, et al. The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial. Am Heart J 2018; 200: 83-9.
20. Raz I, Mosenzon O, Bonaca MP, et al. DECLARE-TIMI 58: participants baseline characteristics. Diabetes Obes Metab 2018; 20: 1102-10.
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
22. Hicks KA, Mahaffey KW, Mehran R, et al. 2017 Cardiovascular and stroke endpoint definitions for clinical trials. Circulation 2018; 137: 961-72.
23. Burman CF, Sonesson C, Guilbaud O. A recycling framework for the construction of Bonferroni-based multiple tests. Stat Med 2009; 28: 739-61.
24. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-200.
25. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2018 executive summary. Endocr Pract 2018; 24: 91-120.
26. Imprialos KP, Boutari C, Stavropoulos K, Doumas M, Karagiannis AI. Stroke paradox with SGLT-2 inhibitors: A play of chance or a viscosity-mediated reality? J Neurol Neurosurg Psychiatry 2017; 88: 249-53.
27. Khouri C, Cracowski JL, Roustit M. SGLT-2 inhibitors and the risk of lowerlimb amputation: is this a class effect? Diabetes Obes Metab 2018; 20: 1531-4.
28. Garg SK, Peters AL, Buse JB, Danne T. Strategy for mitigating DKA risk in patients with type 1 diabetes on adjunctive treatment with SGLT inhibitors: A STICH protocol. Diabetes Technol Ther 2018; 20: 571-5.
29. Fitchett , Zinman B, Wanner C, et al Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME trial Eur Heart J. 2016 vol 37 pp 1526-34
30. Fitchett DH, Udell JA, Inzucchi SE. Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes. Eur J Heart Fail 2017; 19: 43-53.
31. Heerspink HJL, Kosiborod M, Inzucchi SE, Cherney DZI. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int 2018; 94: 26-39.
32. Sattar N, McGuire DK. Pathways to cardiorenal complications in type 2 diabetes mellitus: A need to rethink. Circulation 2018; 138: 7-9.
33. Bloomgarden Z. The kidney and cardiovascular outcome trials. J Diabetes 2018; 10: 88-9.
34. MacIsaac RJ, Jerums G, Ekinci EI. Cardio-renal protection with empagliflozin. Ann Transl Med 2016; 4: 409.
35. Bhatt DL, Mehta C. Adaptive designs for clinical trials. N Engl J Med 2016; 375: 65-74.